Home / Aprepitant / France
FR ATC A04AD12 · updated 2 Nov 2026
Aprepitant shortage in France
Is there an Aprepitant shortage in France?
Yes. As of 2 Nov 2026, 2 Aprepitant products are reported short in France, the first since 2 Nov 2024. No return date has been given. Main reason: not stated.
Also short in United States, Canada, Germany, Italy, Spain, Ireland, Austria, Czechia, Norway, Sweden, Australia. All countries.
Affected products in France
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| FR | Spécialités à base d'aprépitant 125 mg, 80 mg et 125 mg/80 mg gélules limited | 2 Nov 2024 | not given | Not stated | |
| FR | Emend 125 mg, poudre pour suspension buvable limited | 9 Jan 2026 | not given | Not stated |
Source
ANSM (French National Agency for Medicines and Health Products Safety). Official list. Medicines of major therapeutic interest in stock-out, supply tension or discontinuation; one row per communication.